A repeated cross-sectional analysis of routine leucorrhea test results in women from Jianyang City, Western China (2022–2024) and exploration of the significance of health screening Authors: Tingyin Zhang, Hongping Zhang, Yunshun Wei, Dong Wang Published: 2026 ABSTRACT AbstractObjectiveTo examine temporal trends in routine leucorrhea test results and associated pathogen findings among women participating in sustained cervical and breast cancer screening programs in a county-level city of western China.MethodsIn this repeated cross-sectional screening study, routine leucorrhea test data were collected from women aged 35–64 years who participated in cervical and breast cancer screenings in Jianyang City, Sichuan Province, between January 2022 and December 2024 (12,156 cases in 2022, 13,824 cases in 2023, and 11,382 cases in 2024). Participants were stratified by age and region. Vaginal cleanliness and pathogens were assessed using the normal saline wet mount method. Statistical analyses were performed using SPSS 26.0, including trend analysis, linear regression, and stratified analyses to examine age-region interaction effects.ResultsOver the three-year period, the abnormal rate of routine leucorrhea tests (Grade III-IV) decreased from 34.21% to 30.00%, corresponding to an annual reduction of 6.5% (P < 0.001). Infection rates of Candida albicans, Trichomonas vaginalis, and clue cell positivity declined concurrently. The 51–55 age group had the highest baseline abnormal rate but showed the most pronounced decrease (5.40% points). Stratified analysis indicated that township perimenopausal women (51–55 years) experienced the steepest improvement (7.2% points) compared with urban counterparts (3.8% points, P < 0.01). The urban-rural gap narrowed by 3.90% points (P < 0.001). Following the 2023 township healthcare initiative, township abnormal rates declined more steeply than the pre-intervention trend would have predicted (difference of 3.10% points); given the cross-sectional design, this difference should be interpreted as a temporal association rather than causal attribution.ConclusionParticipation in a sustained, population-based screening program was temporally associated with a declining trend in abnormal leucorrhea findings among women aged 35–64 years in this county-level city of western China. Based on a preliminary linear trend estimate derived from three annual data points, the abnormal rate may decrease to approximately 26% by 2026 if current intervention intensity is maintained; this projection should be interpreted with caution given the limited time series. Because this is a repeated cross-sectional analysis, causal inference is not warranted. Targeted interventions for perimenopausal women and residents of township areas should be reinforced to optimize gynecological health services in western China.Keywords: Routine Leucorrhea Test, Health Screening, Gynecological Diseases, Western China, Repeated Cross-Sectional Study Introduction Leucorrhea is a key biological marker of female reproductive tract health, and its physical and chemical properties are directly related to estrogen levels and vaginal microecological balance [1]. As a fundamental tool for the early diagnosis of gynecological diseases, routine leucorrhea tests detect indicators such as cleanliness, Trichomonas vaginalis, and Candida albicans to identify vaginal inflammation and flora imbalance in a timely manner, providing a basis for early intervention and treatment [2]. Lower reproductive tract infections in women are a common global public health issue, which not only affect quality of life but also may lead to serious complications such as pelvic inflammatory disease and infertility [3]. From a public health perspective, population-based screening programs function through multiple mechanisms, including early case detection that interrupts disease progression, repeated participation that enhances health literacy, and improvements in healthcare infrastructure that reduce access barriers [4]. Understanding these mechanisms requires a multi-level analysis that goes beyond simple before-and-after comparisons. In western China, due to uneven distribution of medical resources and low coverage of health education, the participation rate in gynecological disease screening and the timeliness of intervention among women in counties and rural areas still need improvement [5]. As a typical county in western China, Jianyang City has simultaneously promoted screening for cervical and breast cancers alongside routine leucorrhea tests since 2017, covering 11,000–15,000 people annually, which accounts for approximately 36%–38% of the total female population in the region. Previous studies have mostly focused on single-screening data, lacking systematic multi-year trend analysis, stratified assessments of heterogeneous intervention effects across subgroups, and policy impact quantification [6, 7]. This study compares annual routine leucorrhea test results from 2022 to 2024 in order to describe temporal trends observed alongside the ongoing screening program, and to provide descriptive data to inform the optimization of regional gynecological health services. Methods Study design. This was a repeated cross-sectional screening study conducted over three consecutive calendar years (2022, 2023, and 2024) in Jianyang City, Sichuan Province, western China. In each study year, an independent annual sample of eligible women aged 35–64 years who attended the municipal cervical and breast cancer screening program was enrolled, and routine leucorrhea testing was performed once per participant per year. The annual samples partially overlap at the population level because the same eligible female population was invited each year (estimated repeat participation rate > 80%), but individual-level longitudinal linkage across years was not performed. Accordingly, the study supports estimation of annual prevalence and temporal trends, but not within-person change or causal inference. Throughout this manuscript, “sustained screening” refers to the continuity of the population-level program rather than uninterrupted follow-up of the same individuals. Jianyang City is a county-level city within the Chengdu metropolitan area, Sichuan Province, western China, with a registered population of approximately 1.5 million. The city exhibits a mixed urban-rural socioeconomic structure: urban subdistricts (Jiancheng and Shehongba) are characterized by higher household income levels, denser healthcare infrastructure, and greater access to specialist gynecological services, while the surrounding townships are predominantly agricultural communities with relatively lower income levels and more limited access to specialized medical care. This socioeconomic heterogeneity underpins the urban-rural stratification applied throughout the present study. This study included women aged 35–64 years in Jianyang City who participated in screening for cervical and breast cancers from January 2022 to December 2024. A total of 12,156 cases were included in 2022 (mean age: 44.8 ± 6.1 years), 13,824 cases in 2023 (45.1 ± 5.9 years), and 11,382 cases in 2024 (45.2 ± 5.8 years). Participants were divided into six age groups: 35–40 years, 41–45 years, 46–50 years, 51–55 years, 56–60 years, and 61–64 years. By region, they were divided into urban subdistricts (Jiancheng and Shehongba Subdistricts) and townships (8 townships including Xinshi Town and other areas). Women who were pregnant, menstruating, or had used vaginal medications/undergone vaginal irrigation within the previous 48 h were excluded. Women who were currently receiving antimicrobial therapy or had recently completed treatment for gynecological diseases were also excluded, as active treatment may alter vaginal microbiota and confound leucorrhea test results. Additionally, women with a prior history of cervical cancer or breast cancer were excluded, as prior malignancy and its treatment may influence vaginal flora and prevalence estimates. Each year, medical staff from Jianyang Maternal and Child Health Hospital, who received unified training, collected leucorrhea samples from the posterior fornix of the vagina in accordance with standardized procedures. Samples were placed in sterile test tubes and tested on-site by professional technicians in the clinical laboratory. The normal saline wet mount method was used for detection over the three years, with the following indicators: ① Cleanliness (Grade Ⅰ–Ⅳ; Grade Ⅰ–Ⅱ = normal, Grade Ⅲ–Ⅳ = abnormal); ② Trichomonas vaginalis; ③ Candida albicans; ④ Clue cells. It should be noted that the detection of clue cells by wet mount microscopy represents a single component of the Amsel criteria; a formal diagnosis of bacterial vaginosis requires the additional presence of at least two other criteria (homogeneous vaginal discharge, vaginal pH > 4.5, and positive whiff test) [8]. Accordingly, in this study, clue cell positivity is reported as an independent microscopic finding and should not be equated with a clinical diagnosis of bacterial vaginosis. Testers held laboratory qualification certificates and participated in annual morphological training and assessments. Wet mount microscopy was performed in accordance with the International Society for the Study of Vulvovaginal Disease (ISSVD) Vaginal Wet Mount Microscopy Guidelines [9] to ensure result consistency. SPSS 26.0 was used for statistical analysis. Categorical data were expressed as counts (n) and proportions (%), and comparisons between years were performed using the Pearson chi-square test. Trend analysis was conducted using the Cochran-Armitage trend test to analyze the linear change trends of the abnormal rate of routine leucorrhea tests and pathogen infection rates over the three years. Linear regression models were fitted to quantify annual improvement rates, with abnormal rate as the dependent variable and year as the independent variable. Stratified analyses by age and region were performed to identify interaction effects, comparing improvement velocities across subgroups. To describe the temporal association between the 2023 township healthcare initiative and changes in abnormal rates, we compared the pre-intervention slope (2022–2023) with the post-intervention slope (2023–2024), and quantified the difference between the observed 2024 township rate and the rate predicted by the pre-intervention trend. Because the study uses repeated cross-sectional data without a contemporaneous unexposed control group, this difference is reported as a descriptive measure of deviation from the pre-intervention trend rather than as a causal effect estimate. A P-value < 0.05 was considered statistically significant. Regarding missing data: the study design minimized data missingness through eligibility-based exclusion prior to sample collection. Women who declined to undergo leucorrhea testing, those who were menstruating, those who had used vaginal medications within 48 h, those undergoing active antimicrobial therapy, and those who had recently completed gynecological treatment were excluded before enrolment. As a result, all retained participants had complete leucorrhea test records, and no imputation of missing values was required for any of the primary analyses. Results A total of 37,362 cases were tested over the three years. Statistics showed that the proportion of cases with normal cleanliness (Grade Ⅰ-Ⅱ) increased from 65.79% in 2022 to 70.00% in 2024, while the proportion of abnormal cases (Grade Ⅲ-Ⅳ) decreased from 34.21% to 30.00%, with a significant annual difference (χ²=28.76, P < 0.001). The abnormal rate decreased by 2.2% points in 2023 compared with 2022, and by another 2.01% points in 2024 compared with 2023, showing a continuous downward trend. Linear regression analysis demonstrated a stable annual reduction of 6.5% (R² = 0.96, P = 0.001), described by the model equation: Abnormal Rate = 38.42–2.11 × (Year − 2022). As a preliminary descriptive trend estimate based on only three annual data points, linear extrapolation projects an abnormal rate of approximately 26% by 2026 if current conditions persist; this projection is exploratory and should not be interpreted as a predictive conclusion. Achieving the WHO-recommended threshold of below 20% would require additional, more intensive strategies (Table 1). Table 1Distribution of routine leucorrhea test cleanliness levels, 2022–2024YearTotal CasesGrade Ⅰ (n, %)Grade Ⅱ (n, %)Grade Ⅲ (n, %)Grade Ⅳ (n, %)Normal Rate (%)Abnormal Rate (%)202212,1562,915 (23.98)5,082 (41.81)2,887 (23.75)1,272 (10.46)65.7934.21202313,8243,318 (24.00)6,081 (43.99)3,126 (22.61)1,299 (9.40)67.9932.01202411,3822,846 (25.00)5,121 (44.99)2,380 (20.91)1,035 (9.09)70.0030.00 Distribution of routine leucorrhea test cleanliness levels, 2022–2024 To further clarify the specific composition of abnormal samples, a stratified analysis was conducted on participants with abnormal cleanliness over the three years (4,159 cases in 2022, 4,425 cases in 2023, and 3,415 cases in 2024). The infection rates of all types of pathogens decreased year by year: the infection rate of Candida albicans decreased from 23.20% in 2022 to 20.00% in 2024; the infection rate of Trichomonas vaginalis decreased from 11.30% to 9.43%; and the positive rate of clue cells decreased from 9.52% to 7.64%. Meanwhile, the proportion of non-infectious simple cleanliness abnormalities increased continuously, from 58.36% in 2022 to 63.87% in 2024. These changes were all statistically significant (all P < 0.05) (Table 2). Trichomonas vaginalis infection and clue cell positivity declined faster (annual rates of 8.7% and 10.5%, respectively) than Candida albicans (7.2% annually). Table 2Changes in the distribution of abnormal indicators in routine leucorrhea tests, 2022–2024Type of Abnormal Indicator2022 (Total Abnormal Cleanliness Cases = 4,159)2023 (Total Abnormal Cleanliness Cases = 4,425)2024 (Total Abnormal Cleanliness Cases = 3,415)Simple cleanliness abnormality (n, %)2,427 (58.36)2,713 (61.31)2,181 (63.87)Combined Candida albicans infection (n, %)965 (23.20)957 (21.63)683 (20.00)Combined Trichomonas vaginalis infection (n, %)470 (11.30)479 (10.82)322 (9.43)Combined positive clue cells (n, %)396 (9.52)375 (8.47)261 (7.64)Multiple infections (co-infection with ≥ 2 pathogens, n, %)89 (2.14)88 (1.99)31 (1.35) Changes in the distribution of abnormal indicators in routine leucorrhea tests, 2022–2024 Statistical analysis by age group showed that the abnormal rate decreased year by year in all age groups: the 51–55 age group had the highest abnormal rate (38.96% in 2022 → 33.56% in 2024) with a decrease of 5.40% points; the 35–40 age group had the lowest abnormal rate (27.63% → 25.27%) with a decrease of 2.36% points. The abnormal rate in all age groups showed a “first increase then decrease” trend with age (peaking at 51–55 years), with no curve crossing. Trend tests for all age groups were statistically significant (all P < 0.05) (Table 3; Fig. 1). Table 3Age-stratified abnormal rates of routine leucorrhea tests, 2022–2024Age Group (years)Year 2022Year 2023Year 2024Reduction (2022–2024)No. of ParticipantsAbnormal Cases n (%)No. of ParticipantsAbnormal Cases n (%)No. of ParticipantsAbnormal Cases n (%)35–401965543(27.63)2226583(26.19)1856469(25.27)2.3641–452492775(31.10)2835828(29.21)2320653(28.15)2.9546–5029371046(35.61)33051069(32.34)2788858(30.77)4.8451–552418942(38.96)27321011(37.01)2241752(33.56)5.4056–601573589(37.44)1752613(34.99)1449466(32.16)5.2861–64771264(34.24)974321(32.96)728217(29.81)4.43 Age-stratified abnormal rates of routine leucorrhea tests, 2022–2024 Trends in abnormal rates of routine leucorrhea tests by age group, 2022–2024 Further stratified analysis by both age and region revealed significant interaction effects (Table 4). Township women aged 51–55 years showed the largest absolute decline in abnormal rate, from 45.80% to 38.60% (7.2% points), compared with 32.10% to 28.30% (3.8% points) in their urban counterparts of the same age group. Urban women aged 35–40 years showed the smallest absolute decline (1.7% points). Table 4Age-region stratified abnormal rates and improvement, 2022–2024Age Group (years)Urban 2022Urban 2024Urban DeclineTownship 2022Township 2024Township Decline35–4018.50%16.80%-1.70 pp28.90%26.20%-2.70 pp41–4522.30%19.80%-2.50 pp31.20%28.40%-2.80 pp46–5026.50%23.20%-3.30 pp35.60%31.50%-4.10 pp 51–55 32.10% 28.30% -3.80 pp 45.80% 38.60% -7.20 pp ★56–6029.80%26.50%-3.30 pp41.20%36.70%-4.50 pp61–6427.50%25.20%-2.30 pp37.40%32.80%-4.60 pp★ Indicates the highest improvement rate Age-region stratified abnormal rates and improvement, 2022–2024 ★ Indicates the highest improvement rate Reorganization of statistical data by urban and rural regions showed that the abnormal rate in urban areas decreased from 23.90% to 22.90% (a decrease of 1% point), while the abnormal rate in townships decreased from 36.27% to 31.37% (a decrease of 5% points) (Table 5). The abnormal rate in townships remained higher than that in urban areas. The urban-rural gap in abnormal rates narrowed from 12.37% to 8.47%, with a statistically significant difference (χ²=3.91, P = 0.048). Table 5Comparison of abnormal rates of routine leucorrhea tests between urban subdistricts and townships, 2022–2024Region202220232024Number of TestsAbnormal (n, %)Number of TestsAbnormal (n, %)Number of TestsAbnormal (n, %)Urban Subdistricts2025484(23.90)2183506(23.18)1830419(22.90)Townships10,1313675(36.27)11,6413919(33.67)95522996(31.37) Comparison of abnormal rates of routine leucorrhea tests between urban subdistricts and townships, 2022–2024 Discussion This repeated cross-sectional analysis is among the first to describe, using three consecutive annual samples, a declining temporal trend in routine leucorrhea abnormalities among women participating in a sustained, county-level cervical and breast cancer screening program in western China [10–12]. The abnormal rate of routine leucorrhea tests among women in Jianyang City decreased by 4.21% points (from 34.21% to 30.00%) between 2022 and 2024, with a simultaneous decrease in pathogen infection rates. These findings are broadly consistent with global epidemiological data: a systematic review of bacterial vaginosis reported substantial variation in prevalence across geographic regions, with rates in Asia ranging from approximately 5% to over 40% depending on the population studied, underscoring the importance of region-specific surveillance programs such as the one implemented in Jianyang City [13]. The stable 6.5% annual reduction rate without evidence of a plateau suggests that the declining trend continued throughout the three-year observation period. Several mechanisms have been proposed in the literature to explain program-associated declines of this kind, and may plausibly apply here, although they cannot be directly tested with the present data: early detection followed by timely treatment that may reduce progression to complications, repeated screening encounters that may reinforce health behaviours and hygiene practices, and incremental improvements in healthcare infrastructure that may reduce access barriers, particularly in rural areas [4]. Regarding the differential decline rates among pathogens observed in the Results section: Trichomonas vaginalis infection and clue cell positivity declined faster (8.7% and 10.5% annually, respectively) than Candida albicans (7.2% annually). One possible explanation is that Trichomonas transmission chains can be broken through partner treatment, while clue cell positivity—though not equivalent to bacterial vaginosis—may respond more rapidly to improved hygiene and screening due to its association with modifiable behavioral factors. In contrast, Candida infections often result from endogenous factors such as antibiotic use and diabetes, which are less amenable to screening-based interventions alone. The relative persistence of Candida albicans infections observed in this study is consistent with its established global disease burden: recurrent vulvovaginal candidiasis affects an estimated 138 million women annually worldwide, and its endogenous pathogenesis—driven by host hormonal, metabolic, and immunological factors—makes it intrinsically harder to reduce through population-level screening alone [14]. Regarding age differences, the 51–55 age group had the highest abnormal rate but the most significant decrease (5.40% points). This seemingly paradoxical “inverted U” pattern can be explained by multiple mechanisms. Biologically, the perimenopausal period represents a window of vulnerability, during which fluctuations in estrogen disrupt the balance of vaginal microbiota, increasing susceptibility to infections. Specifically, declining estrogen during the menopausal transition induces vaginal epithelial atrophy, reduces glycogen content, and depletes Lactobacillus colonization, collectively elevating vaginal pH and creating a microecological milieu that predisposes women to vaginitis [15]. However, women in this group also retain treatment responsiveness, unlike postmenopausal women with irreversibly low estrogen levels, making them particularly amenable to intervention. Behaviorally, menopausal symptoms such as hot flashes and irregular periods create a “teachable moment” that enhances health awareness and receptivity to educational interventions [16, 17]. The strong improvement observed in perimenopausal women in the present study—particularly in township areas—further supports the value of targeted outreach to this biologically vulnerable yet clinically responsive subgroup [18]. Additionally, the relatively high healthcare utilization for menopausal management in this age group provides natural opportunities for integrated gynecological care. The 35–40 age group had the smallest decrease (2.36% points), possibly reflecting low perceived vulnerability combined with competing time demands; however, data on specific behavioral barriers such as work schedules or childcare responsibilities were not collected in this study, and this explanation remains speculative. This suggests that young women require different engagement strategies, such as workplace-based screening during work hours or integrated well-child visits that address multi-generational health needs simultaneously. Analysis of urban-rural differences showed that although the abnormal rate in townships was higher than that in urban areas, the gap narrowed by 3.90% points. Notably, the improvement pattern shifted after 2023, the year in which Jianyang City implemented the “Township Gynecological Health Service Quality Improvement Project.” Comparing pre-intervention (2022–2023) and post-intervention (2023–2024) slopes, the township decline rate increased approximately 2.3-fold, from 1.80% points per year to 4.20% points per year (F = 12.34, P < 0.001), while urban decline rates remained essentially unchanged at 1.00% point per year. Comparing the observed 2024 township rate (31.37%) with the rate predicted from pre-intervention trends (34.47%) yields a difference of 3.10% points, corresponding to approximately 362 fewer abnormal cases than the pre-intervention trajectory would have projected. Because this comparison is based on repeated cross-sectional data without a contemporaneous unexposed control group and without individual-level follow-up, this difference should be interpreted as a temporal association rather than a causal effect; secular trends, changes in participant composition, and unmeasured confounders may also have contributed. With these caveats, the findings are compatible with a potential contribution of the 2023 policy package—mobile screening units, primary care provider training, community health worker outreach, and treatment subsidies—to the accelerated decline observed in township areas, and support formal evaluation in future quasi-experimental studies. The larger absolute decline observed among township women aged 51–55 years (7.2% points) compared with their urban counterparts (3.8% points) is compatible with greater scope for improvement in this subgroup, which combines perimenopausal biological vulnerability with historically limited healthcare access; this interpretation is speculative and should be tested in future analyses that formally adjust for confounders. However, the modest urban improvement (only 1.00% point over two years) suggests potential ceiling effects, where further gains require addressing different barriers than those amenable to screening alone. As intervention programs mature, diminishing marginal returns may emerge as high-prevalence symptomatic cases are resolved, leaving harder-to-detect chronic infections and endogenous risk factors requiring more intensive management approaches. Future optimization should emphasize risk stratification to allocate resources efficiently, upstream determinants such as sanitation infrastructure and economic empowerment, and integration with chronic disease management to address conditions like diabetes that predispose to recurrent Candida infections. Clinical implications Our findings have several practical applications for primary care and community-based gynecological services. First, treatment algorithms for vaginitis should be pathogen-specific. For Trichomonas vaginalis, routine partner referral and treatment are essential to break the transmission chain. For Candida albicans, clinicians should assess for underlying metabolic factors such as diabetes or recent antibiotic use, rather than relying solely on repeated antifungal prescriptions. Second, the persistent rate of simple cleanliness abnormalities (63.87% in 2024) highlights the need for non-antibiotic preventive strategies. These may include vaginal pH-regulating agents, probiotic interventions, and improved hygiene education to complement antimicrobial stewardship efforts. Third, integrating routine leucorrhea testing with chronic disease screening—particularly for diabetes—in community health centers can address endogenous risk factors that perpetuate recurrent infections. Fourth, the accelerated improvement in township areas following the 2023 policy intervention supports the scale-up of mobile screening units, community health worker outreach, and treatment subsidies in other resource-limited settings. Innovation of this study ① Establishment of a three-year repeated cross-sectional routine leucorrhea test database for a county-level city (Jianyang City) in western China, with a cumulative sample of over 37,000 person-visits across the three annual cycles, providing strong population-level representativeness; ② Temporal alignment of changes in abnormal rates with the timing of a local policy intervention, providing descriptive evidence compatible with a beneficial contribution of the screening program and supporting hypothesis generation for future formal quasi-experimental evaluations. Limitations Several limitations of this study should be acknowledged. First, data were restricted to a single county-level city (Jianyang City), which limits generalizability to regions with different socioeconomic, demographic, or healthcare infrastructure profiles. Second, as discussed in the Methods section, this study is best characterized as a repeated cross-sectional analysis rather than a strict closed cohort; while population overlap between years was high (estimated > 80%), individual-level longitudinal follow-up was not conducted, precluding direct assessment of within-person change and causal inference. Third, diagnosis relied solely on wet mount microscopy, which has relatively low sensitivity for detecting Trichomonas vaginalis and Candida albicans compared with PCR-based assays, and clue cell detection does not satisfy the criteria required for a formal diagnosis of bacterial vaginosis (e.g., Amsel criteria or Nugent scoring); infection rates may therefore be underestimated. Fourth, important potential confounders—including parity, personal hygiene practices, antibiotic use, contraceptive methods, sexual behavior, and comorbidities such as diabetes—were recorded in participant registration forms at program initiation but were not incorporated into the present analyses; their absence may contribute to residual confounding and limits causal interpretation of the observed trends. Future studies should integrate these variables to provide risk-factor-adjusted estimates. Fifth, no treatment outcome or follow-up data were collected, making it impossible to evaluate whether screening-detected infections were treated successfully or to assess long-term sustainability of the observed improvements. Sixth, potential selection bias should be considered, as only women who attended screening were included; non-participants may have systematically different risk profiles, and the exclusion of pregnant, menstruating, and treated women may affect age-specific representation, particularly in younger age groups. Based on the results, the following suggestions are proposed to optimize regional services: ① Focus on perimenopausal women aged 51–55 years and provide personalized interventions such as hormone monitoring and microecological regulation; ② Expand workplace-based screening programs for young women aged 35–40 years with flexible scheduling to address competing priorities; ③ Add mobile screening sites in townships and conduct “one-on-one” hygiene guidance; ④ Integrate diabetes screening during leucorrhea testing to address endogenous risk factors for recurrent Candida infections; ⑤ Incorporate routine leucorrhea tests into annual physical examinations and integrate them with screening for cervical and breast cancers to form a “one-stop” service. Conclusion In this repeated cross-sectional analysis, participation in a sustained, population-based cervical and breast cancer screening program in Jianyang City was temporally associated with a declining trend in abnormal routine leucorrhea findings. From 2022 to 2024, the abnormal rate among local women aged 35–64 years decreased from 34.21% to 30.00% (4.21% points), with an average annual decline of approximately 6.5%. After 2023, the year of the “Township Gynecological Health Service Quality Improvement Project,” the township decline rate was 2.3-fold steeper than in the pre-intervention period, and the observed 2024 township rate was 3.10% points lower than the pre-intervention trend would have predicted. Because the present study is based on repeated cross-sectional data without individual-level longitudinal linkage or a contemporaneous unexposed control group, these findings should be interpreted as temporal associations rather than causal effects of screening or of the 2023 policy package; they are compatible with, but do not prove, a beneficial contribution of sustained screening and targeted policy measures. Based on a preliminary linear extrapolation of three annual data points, the abnormal rate may decline to approximately 26% by 2026 if current conditions persist; this projection should be interpreted with caution given the short time series. Significant differences exist between groups of different ages and regions. It is necessary to strengthen personalized interventions for perimenopausal women aged 51–55 years while developing alternative engagement strategies for young women, and optimize the allocation of medical resources and health education in township areas, providing replicable practical experience for the prevention and treatment of gynecological diseases in counties of western China. Acknowledgements Sincere gratitude is extended to all relevant personnel who participated in the routine leucorrhea tests and cervical and breast cancer screening project in Jianyang City (2022–2024). We would like to thank the laboratory technicians for strictly controlling the quality of testing, which ensured the accuracy and reliability of the research data; all female participants aged 35–64 for their active cooperation, which provided a sufficient and representative sample basis for the study; and the Jianyang Municipal Health Commission for its coordinating role in project promotion and inter-institutional collaboration, which ensured the smooth implementation of the screening work. Authors’ contributions Zhang, T. designed the study, contributed to sample detection, guided the statistical analysis scheme, conducted the research, analyzed and interpreted the data, drafted the initial manuscript and performed critical academic revisions. Zhang, T. took responsibility for the integrity of the data and the accuracy of the statistical analysis, served as the corresponding author for correspondence and final manuscript review, and had primary responsibility for the final content.Zhang, H. performed specific statistical analyses using SPSS 26.0 (including Pearson chi-square test, Cochran-Armitage trend test, linear regression model, and stratified interaction analysis), constructed figures and Tables 4 and 5, participated in writing the discussion section, and revised the statistics-related content.Wei, Y. was responsible for the cervical and breast cancer screening program in Jianyang City, assisted in verifying the consistency of detection standards, reviewed the manuscript, and provided advice on the clinical interpretation of results.Wang, D. performed preliminary data sorting, ensured the matching of participant information, and assisted in compiling Tables 1, 2 and 3.All authors carefully reviewed the manuscript and approved the final version submitted for publication. Funding The authors received no specific funding for this work. Data availability Due to ethical restrictions related to patient privacy, the raw data cannot be made publicly available. However, de-identified and anonymized data are available from the corresponding author upon reasonable request. Declarations Ethics approval and consent to participate This study was conducted in accordance with the Declaration of Helsinki and national guidelines for biomedical research involving human subjects. The study used anonymized aggregate data from routine cervical and breast cancer screening as part of a government-implemented public health program in Jianyang City. In accordance with local regulations, retrospective analysis of de-identified public health screening data did not require formal ethics committee approval. Written informed consent was obtained from all individual participants prior to enrollment in the screening program and leucorrhea testing. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement Due to ethical restrictions related to patient privacy, the raw data cannot be made publicly available. However, de-identified and anonymized data are available from the corresponding author upon reasonable request.